What is TECHLAB?
TECHLAB, Inc. is a prominent developer and manufacturer specializing in infectious disease diagnostics. Their product portfolio includes tests for critical pathogens such as C. difficile, H. pylori, and various foodborne pathogens. Beyond their diagnostic kits, TECHLAB extends its expertise to contract manufacturing and research services, catering to both industrial and academic clients with an emphasis on enhancing laboratory efficiency. The company's commitment to quality is evidenced by its ISO certification and FDA registration, ensuring its diagnostic solutions are suitable for global clinical applications. TECHLAB's core mission is to deliver innovative diagnostic tools for intestinal diseases and other infectious agents.
How much funding has TECHLAB raised?
TECHLAB has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for TECHLAB?
The substantial enterprise-level funding positions TECHLAB for accelerated growth and strategic expansion. This capital infusion is expected to fuel further research and development into novel diagnostic technologies, potentially broadening their test offerings and enhancing existing product lines. The company may also leverage this investment to scale its manufacturing operations, increase market penetration, and forge new strategic partnerships. TECHLAB's focus on improving lab efficiency and providing critical diagnostic solutions suggests a trajectory aimed at solidifying its leadership in the infectious disease diagnostics market.
See full TECHLAB company page
